Abstract: Topically applicable high SPF cosmetic/dermatological UV-screening compositions suited for the photoprotection of the skin and/or hair, comprise (a) particulates of at least one insoluble organic UV-screening agent having a particle size ranging from 10 nm to 5 ?m, as a first screening agent, and (b) at least one 4,4-diarylbutadiene compound, as a second screening agent, formulated into a topically applicable, cosmetically/dermatologically acceptable vehicle therefor.

Abstract: The present invention relates to enhanced efficacy antiperspirant salts containing strontium and an amino acid or a hydroxy acid and particularly to stabilized aqueous solutions of such salts. The present invention also embraces methods of making these antiperspirant salts and solutions and compositions containing same.

Abstract: A cost effective process is provided for making stable, efficacious, amino acid and polyhydric alcohol free concentrated aqueous aluminum zirconium salt solutions. Absence of amino acid, low iron content and low trace metal impurity levels improve compatibility with fragrances and minimizes the probability of the product color change and possibly fabric staining significantly. The novel aluminum zirconium actives also minimize iron contribution to underarm area that supports growth of microflora which is responsible for axillary malodour by the biotransformation of nonodorous precursors present in perspiration. The astringent complexes of the present invention may be obtained in solution or dry powder form. As a result, the complexes are satisfactory for use in any of wide variety of conventional antiperspirant forms.

Abstract: Topically applicable photostable sunscreen/photoprotective compositions contain at least one dibenzoylmethane UV-sunscreen and an effective photostabilizing amount therefor of at least one amphiphilic block copolymer which comprises at least one nonionic hydrophilic polymer block and at least one hydrophobic polymer block, formulated into a topically applicable, cosmetically acceptable medium therefor.

Abstract: The present invention relates to methods and compositions for using photostabilizer compounds for stabilizing formulation ingredients, like flavors, fragrances, colors, antioxidants, polymers, within cosmetics, personal care and household products, against degradation from sun light, heat and air oxidation resulting in improvement in storage stability, viscosity, and maintenance of color of the formulated products.

Abstract: Solid lipid nanoparticle compositions containing (a) 1 to 40% by weight of an oil-soluble UV absorber, (b) 20 to 98.9% by weight of a solid lipid, (c) 0.1 to 20% by weight of an emulsifier and (d) 0 to 40% by weight of a liquid lipid or a liquid oil-miscible UV absorber The compositions according to the invention enhance the solubility behaviour of oil-soluble UV filters in cosmetic formulations and thereby also improve their effectiveness.

Abstract: Disclosed herein are novel methods for reducing or preventing the harmful effects of solar radiation on skin. Also disclosed are novel sunscreen compositions comprising thaizolium, thiadiazolium or triazolium compounds or derivatives and analogs thereof for reducing or preventing the harmful effects of solar radiation on skin. Sunscreen active agents that provide UV-A and UV-B filters are also included. The invention further discloses additional sunscreen active agents, emollients, humectants, dry-feel modifiers, waterproofing agents, insect repellants, antimicrobial preservatives, antioxidants, chelating agents, fragrances and moisturizers, suitable carriers for topical application and emulsions.

Abstract: An amino acid free stable aluminum zirconium polyhydric alcohol aqueous solution having a high anhydrous antiperspirant solid concentration and a high percentage of low molecular weight aluminum species, i.e., containing 60% or more of band IV peak area based on high pressure liquid chromatography, is prepared by adding a zirconium salt to an aqueous polyhydric alcohol solution of a basic aluminum chloride.

Abstract: Exposure of human skin to ultraviolet (UV) radiation from the sun not only induces the production of enzymes (matrix metalloproteinases) that degrade collagen, but also inhibits the synthesis of new collagen by inhibiting the synthesis of procollagen. This UV-induced inhibition of the synthesis of collagen can be prevented by the topical application of a retinoid or c-JUN inhibitor to the skin prior to exposure to UV radiation.

Abstract: A sunscreen composition which includes at least one UV-B active ingredient therein, optionally with a UV-A active, and a phenylethyl or benzyl ester in an amount sufficient to boost the SPF rating of the UV-B active therein.

Abstract: A process for forming a free standing antiperspirant or deodorant solid stick product using particulate and fluid materials that are combined by means of amalgamation, homogenization, compaction and extrusion at a temperature below the melting temperature of said product and extruded by mechanically working the particulate and fluid materials.

Abstract: The invention relates to a preparation having light-protection properties comprising at least one compound of the formula I where R1 and R2 are selected from H and OR11, where each OR11, independently of the others, is OH, a straight-chain or branched C1- to C20-alkoxy group, a straight-chain or branched C3- to C20-alkenyloxy group, a straight-chain or branched C1- to C20-hydroxyalkoxy group, where the hydroxyl group(s) may be bonded to a primary or secondary carbon atom in the chain and furthermore the alkyl chain may also be interrupted by oxygen, and/or a C3- to C10-cycloalkoxy group and/or C3- to C12-cyclo-alkenyloxy group, where the rings may each also be bridged by —(CH2)n— groups, where n=1 to 3, and/or a mono- and/or oligoglycosyl radical, with the proviso that at least one radical from R1 and R2 is OR11, and R3 is a radical OR11, and R4 to R7 and R10 may be identical or different and are, independently of one another, radicals which are substantially inert with respect to the UV properties.

Abstract: The present invention is directed to a cosmetic composition that has an amount of at least two rheology-modifying agents such that the viscosity of the composition remains stable over a broad temperature range. The compositions of the present invention may also include at least one of the following additional components: sunscreen agent, SPF booster, secondary emulsifier, emollient, moisturizer, humectant, film former/waterproofing agent, bio-active (functional) ingredient, pH adjuster/chelating agent, preservative, fragrance, effect pigment, color additive, or any combinations thereof.

Abstract: The present invention relates to new UV-protection formulations with improved stability in respect to crystallisation, characterized in that a compound of formula (1) or a mixture thereof wherein R1 is substituted or unsubstituted C6–C12alkyl, R2, R3 and R4 are independently from each other hydrogen; substituted or unsubstituted C1–C4alkyl, preferably hydrogen; unsubstituted C1–C2alkyl or substituted C1–C2alkyl, more preferably hydrogen. is added to the UV-protection formulation.

Abstract: A formulation for topical application, the formulation comprising a waterborne polyurethane polymer; a thickening agent; a humectant, at least one sunscreen active agent, and an emulsifying agent.

Abstract: The present invention provides a topical drug delivery system which comprises: a therapeutically effective amount of an antifungal agent; at least one dermal penetration enhancer, which is a safe skin-tolerant ester sunscreen ester; and a volatile liquid. The invention also provides a method for administering at least one systemic acting antifungal agent to an animal which comprises applying an effective amount of the antifungal agent in the form of the drug delivery system of the present invention.

Abstract: Aluminum and aluminum-zirconium antiperspirant compositions of enhanced efficacy and a pH value of at least 3.5 are provided that are made by reaction with insoluble, strongly alkaline strontium or calcium salts. The aluminum and aluminum-zirconium strontium or calcium compositions show high pH values with characteristic HPLC Band III to Band II ratios of at least 0.5. The basic aluminum halohydrate (or nitrate) solutions typically have aluminum to anion ratio of less that 1.9. The solution compositions are stable with respect to both HPLC Band III to Band II ratio and viscosity at concentrations of about 20% to about 40% by weight of anhydrous solid. The solid state compositions form hard sticks with low irritation, at low metal to chloride ratios of about 0.9 to about 1.2.

Abstract: The use of hydroxyethers obtainable by ring opening of olefinic oxides having 6 to 18 carbon atoms with alcohols having 1 to 18 carbon atoms andlor polyols having 2 to 18 carbon atoms and 2 to 10 hydroxyl groups or water are proposed as oil bodies in cosmetic and/or pharmaceutial preparations is described.

Abstract: Disclosed herein are novel methods for reducing or preventing the harmful effects of solar radiation on skin. Also disclosed are novel sunscreen compositions comprising 3-[2-(4-diethylaminophenyl)-2-oxoethyl]thiazolium salt for reducing or preventing the harmful effects of solar radiation on skin. Agents that provide UV-A and UV-B filters are also included. The invention further discloses additional sunscreen active agents, emollients, humectants, dry-feel modifiers, waterproofing agents, insect repellants, antimicrobial preservatives, antioxidants, chelating agents, fragrances and moisturizers, suitable carriers for topical application and emulsions.

Abstract: The present invention provides methods of treating early morning pathologies using a time-specific controlled release dosage formulation which is administered prior to sleep, and which permits or achieves delivery of a pharmaceutically active agent effective for the treatment of the specific early morning pathology to be treated, at about the time of awakening. The time-specific controlled release dosage formulation comprises (1) a core including the pharmaceutically active agent(s) effective for the treatment of the early morning pathology, and (2) a swellable polymeric coating layer substantially surrounding the core. The swellable polymeric coating layer delays the release of the pharmaceutically active agent from the core for a predetermined period of time dependent upon the thickness of the swellable polymeric coating layer, to effect delivery of the pharmaceutically active agent at about the time of awakening.